Case Report: Serial 4D-CT evolution from focal leaflet thickening to multileaflet HALT after transcatheter aortic valve replacement in a hemodialysis patient
Open Access
- 3 November 2026
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 2009688
Abstract
Background: Electrocardiographically gated multiphase cardiac computed tomography (4D-CT) is the reference imaging technique for detecting hypoattenuated leaflet thickening (HALT) and assessing associated leaflet-motion abnormalities after transcatheter aortic valve replacement (TAVR). The significance of an isolated abnormality detected during the first postoperative week remains uncertain. Case description: A 51-year-old woman receiving maintenance hemodialysis for 13 years underwent transfemoral TAVR with a 23-mm Edwards SAPIEN 3 valve. A visible prosthetic waist was treated by balloon post-dilatation, reducing the invasive transvalvular gradient from 60 to 1 mmHg. Routine postoperative day-7 ECG-gated 4D-CT, reconstructed in 10 phases across the cardiac cycle, showed focal noncoronary cusp thickening measuring 2.5 mm on short-axis and 2.4 mm on long-axis images, with preserved leaflet motion. The immediate post-TAVR mean gradient was 4 mmHg; the nearest early follow-up examination on postoperative day 6 showed a mean gradient of 11 mmHg and a Doppler velocity index of 0.50. Serial echocardiography subsequently showed progressive hemodynamic deterioration. At approximately 7.5 months, limited-phase ECG-gated CT comprising paired systolic and diastolic reconstructions demonstrated multileaflet HALT with predominant right coronary cusp involvement. The abnormal tissue measured approximately 85 HU, extended 14.7 mm longitudinally, reached a maximal thickness of 3.1 mm, and was associated with an estimated 75% reduction in systolic leaflet excursion. The contemporaneous mean gradient was 25 mmHg and increased to 30 mmHg approximately 3 weeks later. Conclusion: This case documents a temporal sequence from an early focal leaflet abnormality with preserved motion to multileaflet HALT, marked motion restriction, and prosthetic valve hemodynamic deterioration. The sequence supports integrated longitudinal assessment but does not establish that the early focal lesion predicted or caused the subsequent HALT.Keywords
Funding Information
- National Major Science and Technology Projects of China
This publication has 10 references indexed in Scilit:
- 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA)European Heart Journal, 2026
- Cardiac Computed Tomography for Prosthetic Heart Valve AssessmentJACC, 2025
- Ambulatory Electrocardiographic Monitoring Following Minimalist Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2021
- Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical researchEuropean Heart Journal, 2021
- Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic ValvesJACC, 2020
- Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valvesEuropean Heart Journal, 2017
- Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational studyThe Lancet, 2017
- Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2017
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysisThe Journal of Clinical Pharmacology, 2015
- Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic ValvesNew England Journal of Medicine, 2015